Repligen (United States)
Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs.2014 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Repligen (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
53%
Total
Publications
173
Total Open
Publications
91
Total
Citations
6.6K
Open Access
Percentage
53%
Total
Publications
173
Total Open
Publications
91
Total
Citations
6.6K
Breakdown
Publisher Open
18%
Both
23%
Other Platform Open
12%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 21%
15
Hybrid 26%
18
No Guarantees 53%
37
Other Platform Open
Domain 78%
47
Institution 15%
9
Preprint 15%
9
Public 15%
9
Other Internet 13%
8
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 47 |
Europe PMC | Domain | 29 |
DOI | Other Internet | 26 |
University of California - eScholarship University of California | Institution | 8 |
Figshare | Public | 7 |
Semantic Scholar | Public | 6 |
bioRxiv | Preprint | 6 |
University of North Texas - University of North Texas Digital Library | Other Internet | 3 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 3 |
medRxiv | Preprint | 3 |